Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | GLI1 | P08151 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GLI2 | P10070 | 1/20 | 0.39 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MET | P08581 | 2/20 | 0.32 |
| ▸ | PTAFR | P25105 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316207 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL9351380 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2897875 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL10530217 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL10530208 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL1269324 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2897873 | 1.00 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2902703 | 0.93 | PTPN1 (0.56) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2902702 | 0.93 | PTPN1 (0.56) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2902701 | 0.93 | PTPN1 (0.56) | PTPN1MEN1KMT2ACNR2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 631 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | CleanJoule, Inc. (US) | 2026-04-30 | — | — | US | claimed |
| US-11753490-B2 | Method for producing temperature-stable polyalkenylenes | EVONIK OPERATIONS GMBH (DE) | 2023-09-12 | — | — | US | claimed |
| CN-112154168-B | Method for producing temperature-stable ring-opened polycycloolefins | 赢创运营有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116396468-A | High-heat-resistance halogen-free intrinsic flame-retardant polydicyclopentadiene engineering material and preparation method thereof | 安徽建筑大学 | 2023-07-07 | — | — | CN | claimed |
| CN-109265421-B | Method for preparing terpenoid by catalyzing mevalonic acid with bifunctional catalyst | 中国科学院青岛生物能源与过程研究所 | 2022-08-05 | — | — | CN | claimed |
| CN-107636852-B | Method for depositing porous organosilicate glass films for use as resistive random access memories | 弗萨姆材料美国有限责任公司 | 2021-06-25 | — | — | CN | claimed |
| US-10934388-B2 | Cis-polycycloolefins and methods for forming cis-polycycloolefins | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-03-02 | — | — | US | claimed |
| US-20210017310-A1 | Method for producing temperature-stable polyalkenylenes | EVONIK OPERATIONS GMBH (DE) | 2021-01-21 | — | — | US | claimed |
| CN-112154168-A | Process for preparing temperature-stable polyalkenamers | 赢创运营有限公司 | 2020-12-29 | — | — | CN | claimed |
| EP-3322740-B1 | PROCESS FOR PREPARING POLYALKENAMERS FOR PACKAGING APPLICATIONS | EVONIK OPERATIONS GMBH (DE) | 2020-12-23 | — | — | EP | claimed |
| US-5132039-A | Dimethylcyclooctadienes, Surfactant | NAGASE & COMPANY, LTD. (JP) | 1992-07-21 | — | — | US | claimed |
| EP-0419089-A1 | Cleaning compositions and applications thereof | NAGASE & COMPANY, LTD. (JP) | 1991-03-27 | — | — | EP | claimed |
| US-4412047-A | EPOXIDIZING 1,5-DIMETHYLCYCLOOCTA-1,5-DIENE WITH PERACETIC OR PERPROPIONIC ACID | CIBA-GEIGY CORPORATION (US) | 1983-10-25 | — | — | US | claimed |
| EP-0013048-B1 | 8-SUBSTITUTED BICYCLO(3.2.1)OCTANES AND PROCESSES FOR THE PREPARATION THEREOF | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1983-08-24 | — | — | EP | claimed |
| US-4247723-A | Preparation of dihydromyrcenol | SHELL OIL COMPANY (US) | 1981-01-27 | — | — | US | claimed |
| US-4239707-A | USEFUL AS HEAT STABLE LIGANDS FOR CATALYTIC SYSTEMS AND AS CHEMICAL INTERMEDIATES PREPARED FROM 1,5-DIMETHYL-1,5-CYCLOOCTADIENE | SHELL OIL COMPANY (US) | 1980-12-16 | — | — | US | claimed |
| US-4239923-A | Linalool from dimethyloctadiene via epoxide and cyclooctenol | SHELL OIL COMPANY (US) | 1980-12-16 | — | — | US | claimed |
| US-4237322-A | Process for preparation of 1,5-dimethylbicyclo[3,2,1]octan-8-ol | SHELL OIL COMPANY (US) | 1980-12-02 | — | — | US | claimed |
| EP-0013048-A2 | 8-Substituted bicyclo(3.2.1)octanes and processes for the preparation thereof | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1980-07-09 | — | — | EP | claimed |
| US-4166076-A | WITH CATALYST COMPRISING REACTION PRODUCT OF A TRIHYDROCARBYL PHOSPHITE, ARSENITE, OR ANTIMONITE WITH A GROUP 8 COMPOUND | SHELL OIL COMPANY (US) | 1979-08-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | ERG28, DIMT1, MSMO1 | PTPN1 4883/4885MEN1 238/4885KMT2A 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.